🌍 Society & Frontier risk-off · 6–18 months
A what‑if from the future

What if Medicaid cuts and coverage losses dent hospital and provider volumes?

Federal Medicaid eligibility cuts raise the uninsured rate, lifting hospital bad debt and denting elective volumes, pressuring providers and device makers.

21%
our model probability
over 6–18 months
prediction markets — wisdom of the crowd
loading live odds…
Empirically anchored 21% · 90% range 0–46% · 18 analogues · measured class health 24% in 18 mo · 3% held back for the unknown
how we built this number — every step
Measured class rate — health ≈0.1843/yr → 24% in 18 mo24%
Analyst prior · editorial share 99% of the class24%
Pooled · weight 75%22%
Crowd — no liquid market
Reserve 3% · no extremizing (×1.0)22%
Published21%

The class rate is measured from our dated, sourced event library (decade-normalized Poisson — the full table is public at base_rates.json). The variant’s share within its class is the analyst’s editorial call, published so you can audit it. A wider range means thinner precedent. Full recipe: methodology · scored at Reality Check.

The butterfly cascade

How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.

Resolution timeline — how this probability is moving

Our model's odds (gold) over time vs the crowd's (Polymarket, blue), from the past toward the 6–18 months horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. The gold path is an illustrative reconstruction anchored to today's estimate — real dated events, not a live re-estimate history.

loading the timeline…

What it would mean

If this plays out, it is a risk-off shock. Federal Medicaid eligibility cuts raise the uninsured rate, lifting hospital bad debt and denting elective volumes, pressuring providers and device makers. The trigger decomposes into signed root‑shocks — Biotech breakthrough ▼ · Consumer spending ▼ · Risk appetite ▼ — which propagate through our causal graph to the markets below.

If it happens — the markets it would move

Biggest moves first. Projected moves are cascade-model priors; hist A–B% = what comparable past events actually did (measured abnormal returns), and model prior · unmeasured marks markets with no analogue backing yet. Tap any market for its price history.

MarketClassProjected move
1Solana SOLon Hyperliquid 📈 chartCrypto▼ -0.4%
hist -9.24–+3.77%
2Hyperliquid (HYPE) HYPEon HyperliquidCrypto▼ -0.3%
model prior · unmeasured
3Ether ETHon Hyperliquid 📈 chartCrypto▼ -0.3%
hist -3.1–+1.99%
4MicroStrategy MSTRon Hyperliquid 📈 chartEquity▼ -0.4%
hist -6.82–+10.98%
5Nasdaq 100 NDXon Hyperliquid 📈 chartIndex▼ -0.3%
hist -0.37–+0.25%
6Volatility (VIX) VIXon Hyperliquid 📈 chartVol▲ +0.2%
hist -1.26–+2.32%
7Bitcoin BTCon Hyperliquid 📈 chartCrypto▼ -0.2%
hist -3.52–+5.55%
8Tech sector XLK 📈 chartEquity▼ -0.2%
hist -0.57–+0.68%

Probable recommendation

If the scenario above plays out, the probable cross‑asset positioning → a scenario‑conditional read, not personalized investment advice
Cash / hedgeRaise cash and hold the long hedges above; this scenario is net risk-off.
For a common-man portfolio: A typical stock-heavy portfolio is at risk. Consider trimming equities, raising cash, and a small cash hedge.
Also moves (not yet on Hyperliquid): Tech sector -0.2%

Historical precedent — what analogous events actually did

Across 18 analogous events (overlap‑weighted), as abnormal returns — market beta stripped, so it's the event's own effect, not the market backdrop. Shown at 20 days (persistent) and 5 days (immediate); ↺ fades = the two horizons disagree. Confidence = consistency × sample × significance.

Wegovy 2021-06 First mRNA COVID-19 vaccine authorized 2020-12 Casgevy — first CRISPR gene-editing medicine approved 2023-12 mRNA pioneers win the Nobel 2023-10 First genetically-modified pig-to-human heart transplant 2022-01 AlphaFold cracks the protein-folding problem 2020-11 He Jiankui announces CRISPR-edited babies 2018-11 Human Genome Project completed 2003-04 Nikkei 225 record single-day rebound 2024-08 Neuralink implants its first human brain-computer interface 2024-01 LK-99 room-temperature superconductor claim 2023-07 OpenAI releases GPT-4 2023-03 NIF achieves fusion ignition 2022-12 AlphaGo defeats Lee Sedol 2016-03 SpaceX lands an orbital rocket booster 2015-12 2008 global rice crisis: Thai benchmark tops $1,000/ton 2008-04 Soviet August coup attempt against Gorbachev 1991-08 Cuban Missile Crisis 1962-10
AssetHistory saysAbnormal (20d · 5d)HitnConfidencevs cascade
SOL SOLSHORT-8.6% · 5d -8.9%80%11 0.44✓ matches cascade
US dollar DXYSHORT-0.6% · 5d -0.5%70%17 0.32·
Bitcoin BTCLONG+5.8% · 5d -5.1% ↺ fades59%14 0.17⚠ differs
Gold XAULONG+0.6% · 5d -0.1% ↺ fades60%16 0.16·
MSTR MSTRLONG+11.4% · 5d -0.9% ↺ fades55%16 0.09⚠ differs
XLK XLKLONG+0.8% · 5d +0.0%55%16 0.08⚠ differs
ETH ETHSHORT-3.0% · 5d -7.7%55%12 0.07✓ matches cascade
NDX NDXLONG+0.4% · 5d -0.4% ↺ fades55%17 0.06⚠ differs
10y yield DGS10LONG+2bp · 5d +1bp52%17 0.03·
Volatility VIXLONG+2.2% · 5d -5.2% ↺ fades50%17 0.00✓ matches cascade
High-yield credit HYGLONG+0.0% · 5d -0.2% ↺ fades44%15 0.00·

Methodology. Probability and impact are anchored to history and scored against what actually happens — wins and losses, in public, at Reality Check. Crowd odds live from Polymarket & Kalshi. By Vikas Singh, Quantitative Strategist. Updated 2026-07-03.